Session Learning Objectives:

1. Identify patients who should be screened for Non-Alcoholic Fatty Liver Disease (NAFLD) and the modality by which to screen them.  

2. Choose a non-invasive liver fibrosis test to stage liver disease of those patients at risk and interpret results. 

3. Counsel a patient with moderate to severe fibrosis due to fatty liver about treatment options and prospective therapeutics. 

Session Faculty:
Dr. Uri Avissar is a clinician-educator with an expertise in Hepatology and Liver Transplant and a Clinical Associate Professor of Medicine at Boston University,  Presenter, has no relevant financial relationships to disclose.

Session date: 
06/15/2023 - 8:45am to 9:45am EDT
Location: 
zoom
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™

    Boston University Chobanian & Avedisian School of Medicine designates this Live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 1.00 Participation

Please login or register to take this course.